Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.7M Sell
187,289
-1,499,181
-89% -$141M 0.02% 485
2026
Q1
$199M Buy
+1,686,470
New +$209M 0.27% 95
2025
Q3
$8.96M Buy
+61,216
New +$9.25M 0.05% 277

Other funds holding ZTS

CIBC Bancorp USA's ZTS Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Zoetis (ZTS) stake by 89% in Q2 2026, selling an estimated $141M and leaving 187,289 shares worth $13.7M. The position accounts for 0.02% of the portfolio, ranked #485.

CIBC Bancorp USA first reported a position in ZTS in Q3 2025 and has held it in 3 quarters since. The position peaked at $199M in Q1 2026. 1,422 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • CIBC Bancorp USA held 187,289 shares of Zoetis worth $13.7M as of Q2 2026.
  • CIBC Bancorp USA sold 1,499,181 Zoetis shares in Q2 2026, an estimated $141M.
  • Zoetis made up 0.02% of CIBC Bancorp USA's portfolio in Q2 2026, its #485 holding.
  • CIBC Bancorp USA first reported a position in Zoetis in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Zoetis position peaked at $199M in Q1 2026.
  • 1,422 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.